{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-044746","form_type":"8-K","ticker":null,"cik":"0001733413","company_name":"TFF Pharmaceuticals, Inc.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.802280+00:00","generated_at":"2026-06-01T16:20:59.296584+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TFF Pharmaceuticals enters ATM equity offering agreement with H.C. Wainwright","bullets":["Agreement allows sale of common stock at Company's discretion under effective S-3 registration statement.","Agent commission set at 3% of gross proceeds; Company reimburses up to $50,000 in expenses.","Sales may be made through at-the-market offerings, including negotiated and block transactions.","No minimum or maximum offering amount specified; proceeds for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-044746","json":"https://secwatch.observer/filing/0001213900-24-044746.json","markdown":"https://secwatch.observer/filing/0001213900-24-044746.md","text":"https://secwatch.observer/filing/0001213900-24-044746.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733413/000121390024044746/0001213900-24-044746-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733413/000121390024044746/ea0206421-8k_tffpharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T16:20:59.296584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"92aad3f6545df6867004345b84202a36854664ca","claim":"TFF Pharmaceuticals, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2024-05-17).","evidence_excerpt":"On May 17, 2024, TFF Pharmaceuticals, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC (“Agent”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its $0.001 par value common stock (“Common Stock”), through the Agent as its sales agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390024044746/0001213900-24-044746-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Effective","value":"2024-05-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}